1 Lee KW,Kuo WR,Tsai SM,et al.,Different impact from betel quid,alcohol and cigarette:risk factors for pharyngeal and laryngeal cancer[J].Int J Cancer,2005,117:831.

2 Szyfter K.Molecular and cellular changes following exposure to tobacco smoke causing laryngeal cancer.An outline of the problem[J].Przegl Lek,2004,61:1197.

3 Zang LY,Stone K,Pryor WA.Detection of free radicals in aqueous extracts of cigarette tar by electron spin resonance[J].Free Radic Biol Med,1995,19:161.

4 An Y,Kiang A,Lopez JP,et al.Cigarette smoke promotes drug resistance and expansion of cancer stem cell-like side population[J].PLoS One,2012,7:e47919.

5 Zhang DD,Lo SC,Sun Z,et al.Ubiquitination of Keap1,a BTB-Kelch substrate adaptor protein for Cul3,targets Keap1for degradation by aproteasome-independent pathway[J].J Biol Chem,2005,280:30091.

6 Hong YB,Kang HJ,Kwon SY,et al.Nuclear factor(erythroid-derived 2)-like 2regulates drug resistance in pancreatic cancer cells[J].Pancreas,2010,39:463.

7 Rushworth SA,Macewan DJ.The role of Nrf2and cytoprotection in regulating chemotherapy resistance of human leukemia cells[J].Cancers(Basel),2011,3:1605.

8 Housman G,Byler S,Heerboth S,et al.Drug resistance in cancer:an overview[J].Cancers(Basel),2014,6:1769.

9 Haigentz M Jr,Silver CE,Hartl DM,et al.Chemotherapy regimens and treatment protocols for laryngeal cancer[J].Expert Opin Pharmacother,2010,11:1305.

10 Hayes JD,McMahon M,Chowdhry S,et al.Cancer chemoprevention mechanisms mediated through the Keap1-Nrf2pathway[J].Antioxid Redox Signal,2010,13:1713.

11 Sun Z,Zhang S,Chan JY,et al.Keap1controls postinduction repression of the Nrf2-mediated antioxidant response by escorting nuclear export of Nrf2[J].Mol Cell Biol,2007,27:6334.

12 Kensler TW,Wakabayashi N,Biswal S.Cell survival responses to environmental stresses via the Keap1-Nrf2-ARE pathway[J].Annu Rev Pharmacol Toxicol,2007,47:89.

13 Kansanen E,Kuosmanen SM,Leinonen H,et al.The Keap1-Nrf2pathway:Mechanisms of activation and dysregulation in cancer[J].Redox Biol,2013,1:45.

14 Wang XJ,Sun Z,Villeneuve NF,et al.Nrf2enhances resistance of cancer cells to chemotherapeutic drugs,the dark side of Nrf2[J].Carcinogenesis,2008,29:1235.

15 Homma S,Ishii Y,Morishima Y,et al.Nrf2enhances cell proliferation and resistance to anticancer drugs in human lung cancer[J].Clin Cancer Res,2009,15:3423.

16 Hayden A,Douglas J,Sommerlad M,et al.The Nrf2transcription factor contributes to resistance to cisplatin in bladder cancer[J].Urol Oncol,2014,32:806.

17 Reedijk J,Lohman PH.Cisplatin:synthesis,antitumour activity and mechanism of action[J].Pharm Weekbl Sci,1985,7:173.

18 Lee JU,Hosotani R,Wada M,et al.Mechanism of apoptosis induced by cisplatin and VP-16in PANC-1cells[J].Anticancer Res,1997,17:3445.

19 Ji L,Li H,Gao P,et al.Nrf2pathway regulates multidrugresistance-associated protein 1in small cell lung cancer[J].PLoS One,2013,8:e63404.

20 Kim HR,Kim S,Kim EJ,et al.Suppression of Nrf2-driven heme oxygenase-1enhances the chemosensitivity of lung cancer A549cells toward cisplatin[J].Lung Cancer,2008,60:47.